• HTAi 2025 Latin America Policy Forum

    The HTAi 2025 Latin America Policy Forum will take place August 10-12, 2025 in Mexico City, Mexico.

    The Latin America Policy Forum provides a unique opportunity for senior
    HTA representatives from public and private sector organizations in the
    Latin America region to meet annually.

  • HTAi 2025 Asia Policy Forum

    The HTAi 2025 Asia Policy Forum will take place November 5-7, 2025 in Penang, Malaysia. The Asia Policy Forum brings the HTAi Board of Directors, international experts, industry & patient […]

  • HTAi 2026 Global Policy Forum

    HTAi Policy Forums provide the opportunity to interact and network with various stakeholders on a one-on-one basis, have open group discussions around relevant and pertinent topics, and have direct impact […]

  • HTAi Webinar | How to Cover Environmental Aspects for HTA at Hospital Level

    Healthcare systems around the world are increasingly aware of their environmental footprint. At the same time, integrating environmental sustainability into Health Technology Assessment (HTA) processes has become a growing priority. This webinar will explore how hospitals can include environmental criteria when assessing, purchasing, and implementing health technologies.

  • HTAi Webinar | INESSS Strategy for the Integration of Environmental Considerations

    Hosted by the HTAi Environmental Sustainability in HTA (ESHTA) Working Group, this webinar will explore how the Institut national d’excellence en santé et en services sociaux (INESSS) is integrating environmental considerations into health and social care decision-making, with a focus on their evolving strategy and its implications for HTA practice.

  • HTAi Webinar | How Global Policy Changes Are Reshaping HTA for Rare Diseases

    HTAi’s Rare Disease Interest Group will celebrate 2026 Rare Disease Day with a conversation on how global policy changes are reshaping HTA processes for rare disease technologies.

    The webinar aims to update the global HTA community on recent advances in rare disease policy, particularly following the adoption of the World Health Assembly (WHA) Resolution on Rare Diseases, and to explore its implications for HTA systems globally. The multi-stakeholder expert panel will discuss how global policy commitments can translate into meaningful regional, national, and local action within HTA.